Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Environmental Research and Public Health|September 9, 2022
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different PredictorsRaffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.
Pain and Therapy|March 29, 2021
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter StudyRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Pain and Therapy|September 26, 2021
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 PatientsRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
The Journal of Infectious Diseases|May 19, 2017
Development, Use, and Impact of a Global Laboratory Database During the 2014 Ebola Outbreak in West AfricaKara N Durski, Shalini Singaravelu, Junxiong Teo, et al.
Cephalalgia : an International Journal of Headache|March 31, 2026
Transcultural headache medicine: A framework for integrating cultural contexts into headache science and care - a call to action from the International Headache SocietyMario F P Peres, Giancarlo Lucchetti, Homero Vallada, et al.
Annals of Neurology|June 29, 2021
Genome-Wide Association Study Identifies Risk Loci for Cluster HeadacheEmer O'Connor, Carmen Fourier, Caroline Ran, et al.
BMJ Open|September 16, 2024
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UKJames Blackstone, Thomas Williams, Jennifer M Nicholas, et al.
Health Technology Assessment (Winchester, England)|June 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trialThomas Williams, James Blackstone, Nevin John, et al.
Lancet (London, England)|October 4, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trialJeremy Chataway, Thomas Williams, James Blackstone, et al.
Cephalalgia : an International Journal of Headache|April 25, 2025
Evidence-based guidelines for the pharmacological treatment of migraine, summary versionRaffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Pageof 8